Expression Of Chloride Channel Protein Clc-3 In Patients With Allergic Rhinitis - Effect Of Topical Corticosteroid Treatment

Huabin Li,Weiping Wen,Lei Cheng,Jianbo Shi,Hongyan Jiang,Yun Oh,Geng Xu
DOI: https://doi.org/10.1001/archoto.2007.45
2008-01-01
Abstract:Objectives: To determine whether the chloride channel protein CLC-3 is upregulated in patients with allergic rhinitis (AR) and whether topical corticosteroid treatment decreases the expression of CLC-3.Design: Histologic study.Setting: Academic research.Patients: Eighteen patients with AR were included in the study.Main Outcome Measures: Expression of CLC-3 was detected by immunohistochemistry and by reverse transcription-polymerase chain reaction before and at 4 weeks after treatment with the topical corticosteroid mometasone furoate.Results: Strong CLC-3 expression was detected in epithelium and in submucosal glands. An increased presence of CLC-3 was demonstrated in nasal mucosa compared with that in normal nasal tissue. A statistically significant difference in CLC-3 gene expression level was found in nasal tissues before vs at 4 weeks after treatment with mometasone.Conclusions: CLC-3 may have a role in modulating the pathogenesis of AR. Decreased expression of CLC-3 may be the mechanism of action of corticosteroid treatment in controlling AR.
What problem does this paper attempt to address?